Prescription drug · ANDA
Duloxetine NDC 68788-4025
Duloxetine hydrochloride 30 mg/1 · Capsule, Delayed release pellets · Oral · Preferred Phamaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68788-4025-3 | 68788402503 | 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68788-4025-3)Marketed from Sep 15, 2025 | |
| 68788-4025-6 | 68788402506 | 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68788-4025-6)Marketed from Sep 15, 2025 | |
| 68788-4025-9 | 68788402509 | 90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68788-4025-9)Marketed from Sep 15, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Duloxetine
- Generic name (nonproprietary)
- duloxetine
- Active ingredients
- Duloxetine hydrochloride — 30 mg/1
- Dosage form
- Capsule, Delayed release pellets
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090776
- Marketing start
- Listing expires
- Other FDA classes
- Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 68788-4025_c5aac428-d929-4688-a9d5-4e9314aa62ccSPL ID c5aac428-d929-4688-a9d5-4e9314aa62ccSPL set ID c5aac428-d929-4688-a9d5-4e9314aa62ccRxCUI 596930, 596934UNII 9044SC542W
- Pharmacologic class
- Serotonin and Norepinephrine Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468788402503followed by a unit qualifier and the quantityPackage 68788-4025-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Duloxetine delayed-release capsules are indicated for the treatment of: • Major depressive disorder in adults • Generalized anxiety disorder in adults and pediatric patients 7 years of age and older • Diabetic peripheral neuropathic pain in adults • Fibromyalgia in adults and pediatric patients 13 years of age and older • Chronic musculoskeletal pain in adults Duloxetine delayed-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: • Major depressive disorder (MDD) in adults ( 1 ) • Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older ( 1 ) • Diabetic peripheral neuropathi…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090776
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Duloxetine | Duloxetine hydrochloride 20 mg/1 | Capsule, Delayed release pelletsOral | HAWAII REPACK, INC | 85534-0050 |
| Duloxetine | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed release pelletsOral | HAWAII REPACK, INC | 85534-0051 |
| Duloxetine | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed release pelletsOral | Bryant Ranch Prepack | 63629-8748 |
| Duloxetine | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed release pelletsOral | Bryant Ranch Prepack | 71335-1445 |
| Duloxetine | Duloxetine hydrochloride 20 mg/1 | Capsule, Delayed release pelletsOral | Actavis Pharma, Inc. | 0228-2890 |
| Duloxetine | Duloxetine hydrochloride 30 mg/1 | Capsule, Delayed release pelletsOral | Actavis Pharma, Inc. | 0228-2891 |
| Duloxetine | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed release pelletsOral | Actavis Pharma, Inc. | 0228-2892 |
| Duloxetine | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed release pelletsOral | Preferred Phamaceuticals Inc. | 68788-4026 |
| Duloxetine | Duloxetine hydrochloride 30 mg/1 | Capsule, Delayed release pelletsOral | Asclemed USA, Inc. | 76420-236 |
| Duloxetine | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed release pelletsOral | Bryant Ranch Prepack | 72162-1058 |
| Duloxetine HCL DRduloxetine hcl | Duloxetine hydrochloride 30 mg/1 | Capsule, Delayed release pelletsOral | Advanced Rx of Tennessee, LLC | 80425-0086 |
| Duloxetine | Duloxetine hydrochloride 30 mg/1 | Capsule, Delayed release pelletsOral | HAWAII REPACK, INC | 85534-0017 |
| Duloxetine | Duloxetine hydrochloride 30 mg/1 | Capsule, Delayed release pelletsOral | NuCare Pharmaceuticals,Inc. | 68071-3779 |
| Duloxetine | Duloxetine hydrochloride 20 mg/1 | Capsule, Delayed release pelletsOral | Proficient Rx LP | 71205-525 |